Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
Download in electronic PDF format for $75
Abstract: Published information on alternative ways to administer commercial dosage forms may not always be the best option for patients and the hospital staff. There are resources available to research information about drugs and excipients. A compounding pharmacist can review the information and, based on training and experience in compounding, develop a formulation to meet the individual needs of a patient. The tretinoin oral suspension formulation included with this article is an example of how to develop a formulation without a published stability study by utilizing various compounding references and databases.
Related Keywords:
tretinoin, oral suspension, retinoid, retin A, category X, excipients, all-trans-retinoic acid, formulation
Related Categories:
CANCER AND AIDS, DERMATOLOGY, EXCIPIENTS, FORMULATIONS, STABILITIES, COMPATIBILITIES
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
McElhiney Linda F
|
Mar/Apr 2010
Pg. 118-123
|
Tretinoin 10-mg Oral Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 327
|
Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 65-67
|
Women's Oral Health: Is There a Hormonal Link?
Preckshot John
|
Jan/Feb 2004
Pg. 10-14
|
Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 360
|
Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 361
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Pediatric Compounding: Coloring Outside the Lines
Preckshot John
|
Jan/Feb 2001
Pg. 6-8
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
|
Nov/Dec 2005
Pg. 456-461
|
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
|
Mar/Apr 2002
Pg. 155-157
|
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
|
Mar/Apr 2017
Pg. 105-108
|
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
|
Nov/Dec 2018
Pg. 516-526
|
Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017
Pg. 160-163
|
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
|
Jan/Feb 2016
Pg. 6-10
|
Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
|
Mar/Apr 2016
Pg. 155-158
|
Tretinoin 0.1% and Lidocaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 302
|
Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 126-129
|
Return to Top |